Related Experiment Video
Updated: Mar 10, 2026

05:18
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
117
The Physiology of Continuous-Flow Left Ventricular Assist Devices
Hoong Sern Lim1, Neil Howell1, Aaron Ranasinghe1
1University Hospital Birmingham, Edgbaston, Birmingham, United Kingdom.
Journal of Cardiac Failure
|December 20, 2016
Summary
Continuous-flow left ventricular assist devices (LVADs) are increasingly used. Understanding their unique physiology is crucial for effective patient management and accurate interpretation of pump parameters.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
Background:
- Increasing use of continuous-flow left ventricular assist devices (LVADs) due to improved outcomes and plateaued heart transplant rates.
- Growing patient population necessitates specialized management strategies.
- Altered circulatory physiology in LVAD patients presents unique clinical challenges.
Purpose of the Study:
- To review the fundamental design and physiology of continuous-flow LVADs.
- To elucidate the complex interactions between the native heart and LVADs.
- To guide clinicians in interpreting LVAD pump parameters for optimal patient care.
Main Methods:
- Review of axial and centrifugal continuous-flow LVAD designs.
- Analysis of functional anatomy and physiology related to LVADs.
- Discussion of the interplay between the heart and LVAD within the circulatory system.
Main Results:
- Continuous-flow LVADs create a parallel circulation, impacting native systemic and right heart hemodynamics.
- Displayed pump parameters can be misleading without a thorough understanding of LVAD physiology.
- Effective management hinges on comprehending the device's physiological integration.
Conclusions:
- A deep understanding of LVAD physiology is essential for clinicians managing these complex patients.
- Accurate interpretation of pump parameters improves clinical decision-making.
- This review provides foundational knowledge for optimizing LVAD patient care.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
566
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
Physiology of the Heart: The Cardiac Cycle
12.1K
The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
12.1K
Heart Failure VI: Adjunct Therapies
493
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
493

